New Weight Loss Drug Shows Surprising Results In Clinical Trials
Imagine shedding pounds like you just had gastric bypass—without the surgery. That’s the buzz around Eli Lilly’s new weight loss contender. Continue reading…
Search fresh public links, source activity, and post angles for Appetite Suppressant.
Fresh curated links around Appetite Suppressant are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Imagine shedding pounds like you just had gastric bypass—without the surgery. That’s the buzz around Eli Lilly’s new weight loss contender. Continue reading…
GLP-1 medications effectively "turn down the volume" on intrusive food thoughts. In a study of 417 adults, those combining medication with behavioral therapy saw a significantly gr...
The U.S. Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies.
The tablet - orforglipron - is available in the US and could soon launch in the UK.
Want relief from constant cravings without the high cost of GLP-1 drugs like Ozempic and Zepbound? Montana grandmother Jen Jodrey, 53, says a surprise alternative—Contrave weight l...
Experimental drug retatrutide cut weight by nearly 30% in Phase 3 trials, outperforming approved therapies, Eli Lilly says.
MANASSAS, Va., April 19, 2026 /PRNewswire/ -- PureHealth Research has expanded its line of natural GLP-1 supplements, combining clinically studied botanical extracts designed to he...
Researchers have created a next-generation obesity drug that works like a “Trojan horse,” using GLP-1/GIP signals to slip a powerful metabolic enhancer directly into target cells....
The tablet is not yet available in the UK but was approved in the US in December
Некоторые фрукты и ягоды способны естественным образом влиять на аппетит и обмен веществ, имитируя отдельные механизмы действия популярного препарата для снижения веса, заявил кард...
Некоторые фрукты и ягоды способны естественным образом влиять на аппетит и обмен веществ, имитируя отдельные механизмы действия популярного препарата для снижения веса, заявил кард...
The U.S. Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies.
The U.S. Food and Drug Administration has approved a new GLP-1 for weight loss, adding a new once-daily pill to the pharmaceutical competition over the popular drugs.
The U.S. Food and Drug Administration has approved a new GLP-1 for weight loss, adding a new once-daily pill to the pharmaceutical competition over the popular drugs.
People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.
Learn about retatrutide, a new weight-loss drug that works differently than other GLP-1s and helped patients in a clinical trial lose up to 85 pounds.
The FDA has approved a pill from Eli Lilly that could change how millions of Americans take medications to lose weight. The drug is the second GLP-1 pill approved by federal regula...
The world of weight management is evolving faster than ever, and a new drug discovery is setting a historic milestone for obesity treatment.
THURSDAY, April 2, 2026 — A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it moved through review faster than most d...
If you’ve ever finished a satisfying dinner only to find yourself drifting toward the cookie jar an hour later, you’re in good company. Those evening sugar cravings can quietly der...
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to inje...
While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three hormone receptors
WEDNESDAY, April 15, 2026 — The U.S. Food and Drug Administration (FDA) has told Eli Lilly to study possible heart, liver and other risks tied to its new obesity drug Foundayo, ac...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.